Kazushige Mori

3.7k total citations · 2 hit papers
50 papers, 3.0k citations indexed

About

Kazushige Mori is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kazushige Mori has authored 50 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kazushige Mori's work include Electrochemical sensors and biosensors (8 papers), HER2/EGFR in Cancer Research (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Kazushige Mori is often cited by papers focused on Electrochemical sensors and biosensors (8 papers), HER2/EGFR in Cancer Research (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Kazushige Mori collaborates with scholars based in Japan, United States and Switzerland. Kazushige Mori's co-authors include Hideo Ishitsuka, Noriaki Sawada, Masanori Miwa, M Nishida, Masako Ura, Nobuo Shimma, T Ishikawa, Isao UMEDA, Kaori Fujimoto-Ouchi and Koji Sode and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Kazushige Mori

50 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1998 1.0k citations Masanori Miwa, Masako Ura et al. European Journal of Cancer profile →
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

2000 547 citations Kazushige Mori et al. Cancer Chemotherapy and Pharmacology profile →

Peers

Countries citing papers authored by Kazushige Mori

Since Specialization

Citations

This map shows the geographic impact of Kazushige Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazushige Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazushige Mori more than expected).

Fields of papers citing papers by Kazushige Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazushige Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazushige Mori. The network helps show where Kazushige Mori may publish in the future.

Co-authorship network of co-authors of Kazushige Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Kazushige Mori. A scholar is included among the top collaborators of Kazushige Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazushige Mori. Kazushige Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Strategic design and improvement of the internal electron transfer of heme b domain-fused glucose dehydrogenase for use in direct electron transfer-type glucose sensors 2020 ·Biosensors and Bioelectronics ·Kohei Ito, Junko Okuda‐Shimazaki, Katsuhiro Kojima, Kazushige Mori, Wakako Tsugawa, Ryutaro Asano, Kazunori Ikebukuro, Koji Sode	22
2	Designer fungus FAD glucose dehydrogenase capable of direct electron transfer 2018 ·Biosensors and Bioelectronics ·Kohei Ito, Junko Okuda‐Shimazaki, Kazushige Mori, Katsuhiro Kojima, Wakako Tsugawa, Kazunori Ikebukuro, Chien‐Chung Lin, Jeffrey T. La Belle, Hiromi Yoshida, Koji Sode	43
3	Construction and characterization of flavin adenine dinucleotide glucose dehydrogenase complex harboring a truncated electron transfer subunit 2018 ·Electrochimica Acta ·Junko Okuda‐Shimazaki, Noya Loew, (unknown), Katsuhiro Kojima, Kazushige Mori, Wakako Tsugawa, Koji Sode	19
4	Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells 2016 ·BMC Cancer ·(unknown), Yusuke Sasaki, Yasushi Shimonaka, Kazushige Mori, Kaori Fujimoto-Ouchi	24
5	Stabilization of fungi-derived recombinant FAD-dependent glucose dehydrogenase by introducing a disulfide bond 2015 ·Biotechnology Letters ·(unknown), Katsuhiro Kojima, Kazushige Mori, (unknown), Koji Sode	30
6	Structural analysis of fungus-derived FAD glucose dehydrogenase 2015 ·Scientific Reports ·Hiromi Yoshida, (unknown), Kazushige Mori, Katsuhiro Kojima, S. Kamitori, Koji Sode	103
7	Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer 2012 ·Cancer Science ·Naoki Niikura, Takayuki Iwamoto, Shinobu Masuda, Nobue Kumaki, Xiaoyan Tang, Masatoshi Shirane, Kazushige Mori, Banri Tsuda, Takuho Okamura, Yuki Saito, Yasuhiro Suzuki, Yutaka Tokuda	39
8	Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma 2012 ·British Journal of Cancer ·Masayuki Kobayashi, Yasuhiro Miki, Masahito Ebina, Keiko Abe, Kazushige Mori, (unknown), Takashi Suzuki, (unknown), Makoto Maemondo, (unknown), Akira Inoue, Hiroyuki Kumamoto, Takashi Kondo, H. Yamada-Okabe, T. Nukiwa, Hironobu Sasano	24
9	Screening of Aspergillus-derived FAD-glucose dehydrogenases from fungal genome database 2011 ·Biotechnology Letters ·Kazushige Mori, (unknown), Katsuhiro Kojima, (unknown), Stefano Ferri, Koji Sode	36
10	Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts 2011 ·Oncology Reports ·Toshiki Iwai, Yoichiro Moriya, Masatoshi Shirane, Kaori Fujimoto-Ouchi, Kazushige Mori	12
11	Intratumoral Localization of Aromatase and Interaction between Stromal and Parenchymal Cells in the Non–Small Cell Lung Carcinoma Microenvironment 2010 ·Cancer Research ·Yasuhiro Miki, Takashi Suzuki, Keiko Abe, Satoshi Suzuki, Hiromichi Niikawa, Shinya Iida, Shuko Hata, Jun‐ichi Akahira, Kazushige Mori, Dean B. Evans, Takashi Kondo, Hisafumi Yamada‐Okabe, Hironobu Sasano	51
12	Motif‐based search for a novel fructosyl peptide oxidase from genome databases 2010 ·Biotechnology and Bioengineering ·Seungsu Kim, Stefano Ferri, Wakako Tsugawa, Kazushige Mori, Koji Sode	17
13	High expression of thymidine phosphorylase in basal-like breast cancers: Stromal expression in EGFR- and/or CK5/6-positive breast cancers 2010 ·Oncology Letters ·Shinobu Umemura, Masatoshi Shirane, Susumu Takekoshi, Yutaka Tokuda, Kazushige Mori, R. Yoshiyuki Osamura	5
14	Antitumor activity of erlotinib in combination with gemcitabine in in vitro and in vivo models of KRAS-mutated pancreatic cancers 2010 ·Oncology Letters ·Koh Furugaki, Toshiki Iwai, (unknown), Yoichiro Moriya, Kazushige Mori	11
15	Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy 2009 ·Cancer Chemotherapy and Pharmacology ·Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Kaname Yamamoto, Masatoshi Shirane, Yoriko Yamashita, Kazushige Mori	18
16	Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models 2006 ·Cancer Chemotherapy and Pharmacology ·Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Hideyuki Yasuno, Yoichiro Moriya, Kazushige Mori, Yutaka Tanaka	163
17	Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models 2006 ·Cancer Chemotherapy and Pharmacology ·Kaori Fujimoto-Ouchi, Etsuro Onuma, Masatoshi Shirane, Kazushige Mori, Yutaka Tanaka	14
18	Analysis of the function of a hyperthermophilic endoglucanase from Pyrococcus horikoshii that hydrolyzes crystalline cellulose 2004 ·Extremophiles ·(unknown), Kazushige Mori, Harumi Fukada, Kazuhiko Ishikawa	34
19	Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue breakdown → 1998 ·European Journal of Cancer ·Masanori Miwa, Masako Ura, M Nishida, Noriaki Sawada, T Ishikawa, Kazushige Mori, Nobuo Shimma, Isao UMEDA, Hideo Ishitsuka	1039
20	Murine interleukin-12 prevents the development of cancer cachexia in a murine model 1996 ·International Journal of Cancer ·Kazushige Mori, Kaori Fujimoto-Ouchi, Tohru Ishikawa, Fumiko Sekiguchi, Hideo Ishitsuka, Yutaka Tanaka	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact